EOSINOPHILIC GASTRITIS

Clinical trials for EOSINOPHILIC GASTRITIS explained in plain language.

Never miss a new study

Get alerted when new EOSINOPHILIC GASTRITIS trials appear

Sign up with your email to follow new studies for EOSINOPHILIC GASTRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 2 Completed 1

New injection tested for rare stomach disease

Disease control Completed

This study tested whether dupilumab, an injectable medication, could reduce harmful inflammation in the stomachs of people with eosinophilic gastritis. Forty-one participants aged 12-70 received either the drug or a placebo injection every two weeks for 12 weeks. The main goal wa…

Matched conditions: EOSINOPHILIC GASTRITIS

Phase: PHASE2 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control

Last updated Mar 09, 2026 14:26 UTC

EOSINOPHILIC GASTRITIS

Get alerted when new EOSINOPHILIC GASTRITIS trials appear

New injection tested for rare stomach disease